MGC Diagnostics Corporation Stock Price, News & Analysis (NASDAQ:MGCD)

$8.78 0.26 (3.05 %)
(As of 11/20/2017 04:00 PM ET)
Previous Close$8.52
Today's Range$8.51 - $8.78
52-Week Range$6.24 - $10.60
Volume2,030 shs
Average Volume5,731 shs
Market Capitalization$37.56 million
P/E Ratio77.46
Dividend YieldN/A
BetaN/A

About MGC Diagnostics Corporation (NASDAQ:MGCD)

MGC Diagnostics Corporation logoMGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.


Industry, Sector and Symbol:
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NASDAQ:MGCD
  • Previous Symbol: NASDAQ:ANGN
  • CUSIP: N/A
  • Web: www.mgcdiagnostics.com
Debt:
  • Current Ratio: 2.03%
  • Quick Ratio: 1.50%
Price-To-Earnings:
  • Trailing P/E Ratio: 77.46
Sales & Book Value:
  • Annual Sales: $40.04 million
  • Price / Sales: 0.97
  • Cash Flow: $0.51 per share
  • Price / Cash: 17.13
  • Book Value: $3.86 per share
  • Price / Book: 2.27
Profitability:
  • Trailing EPS: ($0.84)
  • Net Income: $-3,770,000.00
  • Net Margins: -8.85%
  • Return on Equity: 3.51%
  • Return on Assets: 1.82%
Misc:
  • Employees: 155
  • Outstanding Shares: 4,410,000
 

Frequently Asked Questions for MGC Diagnostics Corporation (NASDAQ:MGCD)

What is MGC Diagnostics Corporation's stock symbol?

MGC Diagnostics Corporation trades on the NASDAQ under the ticker symbol "MGCD."

How often does MGC Diagnostics Corporation pay dividends? What is the dividend yield for MGC Diagnostics Corporation?

MGC Diagnostics Corporation declared a special dividend on Thursday, January 26th. Stockholders of record on Friday, February 10th will be paid a dividend of $0.70 per share on Friday, February 24th. The ex-dividend date of this dividend is Wednesday, February 8th. This is a positive change from MGC Diagnostics Corporation's previous special dividend of $0.45. View MGC Diagnostics Corporation's Dividend History.

How were MGC Diagnostics Corporation's earnings last quarter?

MGC Diagnostics Corporation (NASDAQ:MGCD) announced its quarterly earnings results on Wednesday, September, 6th. The medical equipment provider reported $0.17 earnings per share for the quarter. The medical equipment provider earned $10.41 million during the quarter. MGC Diagnostics Corporation had a negative net margin of 8.85% and a positive return on equity of 3.51%. View MGC Diagnostics Corporation's Earnings History.

When will MGC Diagnostics Corporation make its next earnings announcement?

MGC Diagnostics Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, January, 24th 2018. View Earnings Estimates for MGC Diagnostics Corporation.

Who are some of MGC Diagnostics Corporation's key competitors?

Who are MGC Diagnostics Corporation's key executives?

MGC Diagnostics Corporation's management team includes the folowing people:

  • Mark W. Sheffert, Independent Chairman of the Board (Age 68)
  • Matthew S. Margolies, President (Age 50)
  • Todd M. Austin, Chief Executive Officer (Age 54)
  • Larry Robert Degen, Interim Chief Financial Officer, Chief Accounting Officer, Secretary (Age 62)
  • John R. Baudhuin, Independent Director (Age 53)
  • Terrence W. Bunge, Independent Director (Age 62)
  • Wendy D. Lynch Ph.D., Independent Director (Age 54)
  • Robert E. Munzenrider CPA, Independent Director (Age 72)
  • Hendrik Struik, Independent Director (Age 49)

How do I buy MGC Diagnostics Corporation stock?

Shares of MGC Diagnostics Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MGC Diagnostics Corporation's stock price today?

One share of MGC Diagnostics Corporation stock can currently be purchased for approximately $8.78.

How big of a company is MGC Diagnostics Corporation?

MGC Diagnostics Corporation has a market capitalization of $37.56 million and generates $40.04 million in revenue each year. The medical equipment provider earns $-3,770,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. MGC Diagnostics Corporation employs 155 workers across the globe.

How can I contact MGC Diagnostics Corporation?

MGC Diagnostics Corporation's mailing address is 350 OAK GROVE PARKWAY, ST PAUL MN, 55127. The medical equipment provider can be reached via phone at 651-484-4874 or via email at [email protected]


MarketBeat Community Rating for MGC Diagnostics Corporation (NASDAQ MGCD)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  51
MarketBeat's community ratings are surveys of what our community members think about MGC Diagnostics Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for MGC Diagnostics Corporation (NASDAQ:MGCD)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for MGC Diagnostics Corporation (NASDAQ:MGCD)

Price Target History for MGC Diagnostics Corporation (NASDAQ:MGCD)

Analysts' Ratings History for MGC Diagnostics Corporation (NASDAQ:MGCD)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History and Estimates Chart for MGC Diagnostics Corporation (NASDAQ:MGCD)

Earnings by Quarter for MGC Diagnostics Corporation (NASDAQ:MGCD)

Earnings History by Quarter for MGC Diagnostics Corporation (NASDAQ MGCD)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/24/2018        
9/6/2017Q3 2017$0.17$10.41 millionViewListenView Earnings Details
6/1/2017Q2 2017($0.01)$9.82 millionViewListenView Earnings Details
3/7/2017Q1 2017($0.07)$8.74 millionViewListenView Earnings Details
1/25/2017Q416$0.27$0.02$10.60 million$11.50 millionViewN/AView Earnings Details
9/7/2016Q316$0.06$9.20 million$9.90 millionViewN/AView Earnings Details
6/1/2016Q216$0.10$8.70 million$9.40 millionViewN/AView Earnings Details
9/10/2015Q315$0.80$9.24 millionViewListenView Earnings Details
6/2/2015Q215$0.02$8.70 millionViewN/AView Earnings Details
3/5/2015Q115($0.13)$8.90 millionViewN/AView Earnings Details
1/7/2015Q414($0.07)$9.70 millionViewN/AView Earnings Details
9/9/2014Q3 14$0.08($0.21)$6.60 millionViewN/AView Earnings Details
6/12/2014Q2 14$0.13$0.07$7.60 million$7.40 millionViewN/AView Earnings Details
3/4/2014Q413$0.08($0.06)$7.01 million$6.30 millionViewN/AView Earnings Details
12/19/2013Q313$0.20$0.20$8.23 million$9.14 millionViewListenView Earnings Details
5/30/2013Q2 2013$0.06$5.60 million$7.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MGC Diagnostics Corporation (NASDAQ:MGCD)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for MGC Diagnostics Corporation (NASDAQ MGCD)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/26/2017special$0.702/8/20172/10/20172/24/2017
3/29/2013special$0.454/10/20134/12/20134/26/2013
4/8/2013special$0.454/12/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for MGC Diagnostics Corporation (NASDAQ MGCD)

Insider Ownership Percentage: 11.00%
Institutional Ownership Percentage: 22.83%
Insider Trades by Quarter for MGC Diagnostics Corporation (NASDAQ:MGCD)

Insider Trades by Quarter for MGC Diagnostics Corporation (NASDAQ MGCD)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/11/2015Wendy D LynchDirectorBuy2,000$5.35$10,700.00View SEC Filing  
1/14/2015Hendrik StruikDirectorBuy3,763$6.22$23,405.86View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MGC Diagnostics Corporation (NASDAQ MGCD)

Source:
DateHeadline
ETFs with exposure to MGC Diagnostics Corp. : November 17, 2017ETFs with exposure to MGC Diagnostics Corp. : November 17, 2017
finance.yahoo.com - November 17 at 4:16 PM
ETFs with exposure to MGC Diagnostics Corp. : October 2, 2017ETFs with exposure to MGC Diagnostics Corp. : October 2, 2017
finance.yahoo.com - October 2 at 11:53 AM
ETFs with exposure to MGC Diagnostics Corp. : September 20, 2017ETFs with exposure to MGC Diagnostics Corp. : September 20, 2017
finance.yahoo.com - September 22 at 5:21 AM
MGC Diagnostics Corp. :MGCD-US: Earnings Analysis: Q3, 2017 By the Numbers : September 18, 2017MGC Diagnostics Corp. :MGCD-US: Earnings Analysis: Q3, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 9:44 PM
MGC Diagnostics (MGCD) CEO Todd Austin on Q3 2017 Results - Earnings Call TranscriptMGC Diagnostics' (MGCD) CEO Todd Austin on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - September 7 at 5:14 AM
MGC Diagnostics Corporation Reports Fiscal 2017 Third Quarter ResultsMGC Diagnostics Corporation Reports Fiscal 2017 Third Quarter Results
finance.yahoo.com - September 7 at 5:14 AM
Edited Transcript of MGCD earnings conference call or presentation 6-Sep-17 8:30pm GMTEdited Transcript of MGCD earnings conference call or presentation 6-Sep-17 8:30pm GMT
finance.yahoo.com - September 7 at 5:14 AM
MGC Diagnostics Corporation (MGCD) Issues  Earnings ResultsMGC Diagnostics Corporation (MGCD) Issues Earnings Results
www.americanbankingnews.com - September 6 at 7:06 PM
MGC Diagnostics Corporation (MGCD) to Release Quarterly Earnings on WednesdayMGC Diagnostics Corporation (MGCD) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - August 31 at 9:10 AM
MGC Diagnostics Corporation to Report Third Quarter Fiscal Year 2017 Financial Results on Wednesday, September 6, 2017MGC Diagnostics Corporation to Report Third Quarter Fiscal Year 2017 Financial Results on Wednesday, September 6, 2017
finance.yahoo.com - August 31 at 7:14 AM
MGC Diagnostics Corporation Added to Russell Microcap IndexMGC Diagnostics Corporation Added to Russell Microcap Index
www.prnewswire.com - June 26 at 9:11 AM
MGC Diagnostics (MGCD) CEO Todd Austin on Q2 2017 Results - Earnings Call TranscriptMGC Diagnostics' (MGCD) CEO Todd Austin on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - June 1 at 7:19 PM
MGC Diagnostics (MGCD) Announces Study to Evaluate Diagnostic Accuracy of FOT to Detect Lung Function AbnormalitiesMGC Diagnostics (MGCD) Announces Study to Evaluate Diagnostic Accuracy of FOT to Detect Lung Function Abnormalities
www.streetinsider.com - April 20 at 6:35 PM
MGC DIAGNOSTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote oMGC DIAGNOSTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o
biz.yahoo.com - March 28 at 6:17 PM
MGC DIAGNOSTICS CORP Files SEC form 8-K, Change in Directors or Principal OfficersMGC DIAGNOSTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 17 at 6:42 PM
MGC Diagnostics (MGCD) CEO Todd Austin on Q1 2017 Results - Earnings Call TranscriptMGC Diagnostics' (MGCD) CEO Todd Austin on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - March 7 at 11:18 PM
Q1 2017 MGC Diagnostics Corp Earnings Release - After Market CloseQ1 2017 MGC Diagnostics Corp Earnings Release - After Market Close
biz.yahoo.com - March 7 at 10:27 AM
MGC Diagnostics cuts compensation for top executivesMGC Diagnostics cuts compensation for top executives
www.bizjournals.com - February 7 at 7:51 PM
MGC DIAGNOSTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhiMGC DIAGNOSTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
biz.yahoo.com - January 26 at 12:57 AM
Q4 2016 MGC Diagnostics Corp Earnings Release - After Market CloseQ4 2016 MGC Diagnostics Corp Earnings Release - After Market Close
us.rd.yahoo.com - January 25 at 7:56 PM
MGC Diagnostics Corporation Reports Fiscal 2016 Fourth Quarter and Year End ResultsMGC Diagnostics Corporation Reports Fiscal 2016 Fourth Quarter and Year End Results
us.rd.yahoo.com - January 25 at 7:56 PM
MGC Diagnostics Corporation Declares $0.70 Per Share Special Cash Dividend and Retains Investment Banking Firm to Explore Strategic OptionsMGC Diagnostics Corporation Declares $0.70 Per Share Special Cash Dividend and Retains Investment Banking Firm to Explore Strategic Options
us.rd.yahoo.com - January 25 at 7:56 PM
4:04 pm MGC Diagnostics Corporation declares a a special cash dividend of $0.70/share and initiates a strategic review of its businesses and assets4:04 pm MGC Diagnostics Corporation declares a a special cash dividend of $0.70/share and initiates a strategic review of its businesses and assets
us.rd.yahoo.com - January 25 at 7:56 PM
MGC Diagnostics revenues up 8% in FQ3MGC Diagnostics revenues up 8% in FQ3
seekingalpha.com - September 8 at 9:58 AM
Q3 2016 MGC Diagnostics Corp Earnings Release - After Market CloseQ3 2016 MGC Diagnostics Corp Earnings Release - After Market Close
biz.yahoo.com - September 7 at 9:40 AM
MGC Diagnostics revenues up 8% in FQ2MGC Diagnostics revenues up 8% in FQ2
seekingalpha.com - June 3 at 8:56 AM
MGC Diagnosticss (MGCD) CEO Todd Austin on Q1 2016 Results - Earnings Call TranscriptMGC Diagnostics's (MGCD) CEO Todd Austin on Q1 2016 Results - Earnings Call Transcript
seekingalpha.com - June 2 at 9:03 AM
MGC Diagnostics (MGCD) Gains Ahead of Quarterly EarningsMGC Diagnostics (MGCD) Gains Ahead of Quarterly Earnings
www.baystreet.ca - June 1 at 6:38 PM
Q2 2016 MGC Diagnostics Corp Earnings Release - After Market CloseQ2 2016 MGC Diagnostics Corp Earnings Release - After Market Close
biz.yahoo.com - June 1 at 7:07 AM
MGC DIAGNOSTICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersMGC DIAGNOSTICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 17 at 2:44 PM
MGC Diagnostics (MGCD) CEO Todd Austin on Q1 2016 Results - Earnings Call TranscriptMGC Diagnostics' (MGCD) CEO Todd Austin on Q1 2016 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 2:20 PM
Q1 2016 MGC Diagnostics Corp Earnings Release - After Market CloseQ1 2016 MGC Diagnostics Corp Earnings Release - After Market Close
biz.yahoo.com - March 8 at 7:07 AM
MGC DIAGNOSTICS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial SMGC DIAGNOSTICS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S
biz.yahoo.com - February 8 at 1:41 PM
MGC DIAGNOSTICS CORP Files SEC form 10-K, Annual ReportMGC DIAGNOSTICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - January 29 at 5:02 PM

Social Media

Financials

Chart

MGC Diagnostics Corporation (NASDAQ MGCD) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.